This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Forschungsverbund Berlin E.v.. Active years: 2011-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2015
Title: Walter Rosenthal: Innovator in Cardiovascular Treatment
Introduction
Walter Rosenthal is a notable inventor based in Kleinmachnow, Germany. He has made significant contributions to the field of medical research, particularly in the treatment of cardiovascular diseases. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
Walter Rosenthal's latest patents include innovative compounds aimed at treating cardiovascular conditions. One of his inventions, titled "N-arylaminomethylene benzothiophenones for treatment of cardiovascular disease," relates to N-arylaminomethylenebenzothiophenones of General Formula (I). This compound is designed for use as a drug to treat cardiovascular diseases, where E can be S, O, or CH, D can be CH or NH, and Ar represents a phenyl or naphthyl moiety that is substituted by an electron-withdrawing group or an unsubstituted heteroaryl residue.
Another significant patent is focused on "Nucleic acid molecules encoding AKAP18 delta, a splice variant of a protein kinase A anchor protein." This invention involves polynucleotides that encode protein kinase A anchor proteins (AKAP) and their use in generating AKAP polypeptides or fusion proteins. The patent also covers methods for determining the interaction of AKAP proteins with regulatory subunits of protein kinase A and identifying cell-permeable substances.
Career Highlights
Walter Rosenthal is associated with Forschungsverbund Berlin E.V., where he continues to advance his research and innovations. His work is characterized by a commitment to improving medical treatments and understanding complex biological processes.
Collaborations
Walter has collaborated with esteemed colleagues such as Enno Klussmann and Martin W. Bergmann. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
Walter Rosenthal's contributions to the field of cardiovascular treatment through his innovative patents demonstrate his dedication to advancing medical science. His work not only reflects his expertise but also holds promise for future developments in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile